Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Frailty × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 14 Genitourinary 7 Other hematologic neoplasm 5 Gynecologic 4 Breast 4 Thoracic 1 Plasma cell 1 NET 1 Myeloid 1 Lymphoid 1 Head & Neck 1 Endocrine 1

Conditions

Neuroendocrine Tumors 338 Carcinoid Tumor 42 Gastro-enteropancreatic neuroendocrine tumor 34 Neoplasms 30 Carcinoma, Neuroendocrine 28 Adenoma, Islet Cell 23 Neoplasm Metastasis 19 Colorectal Neoplasms 19 Pheochromocytoma 18 Paraganglioma 17 Pancreatic Neoplasms 17 Carcinoma 14 Stomach Neoplasms 13 Gastrointestinal Neoplasms 13 Carcinoma, Hepatocellular 13 Sarcoma 12 Prostatic Neoplasms 11 Neuroblastoma 11 Thyroid Neoplasms 10 Breast Neoplasms 10 Small Cell Lung Carcinoma 9 Lung Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Serotonin Syndrome 8 Cholangiocarcinoma 8 Somatostatinoma 7 Neuroectodermal Tumors, Primitive 7 Esophageal Neoplasms 7 Digestive System Neoplasms 7 Carcinoma, Renal Cell 7

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05554003 2024-11-18

MeTe

European Institute of Oncology

Phase 2 Recruiting

Frailty, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡